CTLA4 and head and neck squamous cell carcinoma: In addition, it provides good evidence that the interaction of co-stimulatory molecules in HPV+ HNSCC is effective, given that we detected significantly higher levels of expression of CD152 mRNA, which encodes for the inducible co-inhibitory molecule CTLA-4.